MetLife Investment Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$572K Buy
60,966
+2,420
+4% +$22.7K ﹤0.01% 1612
2025
Q1
$416K Sell
58,546
-641
-1% -$4.56K ﹤0.01% 1813
2024
Q4
$690K Buy
59,187
+3,491
+6% +$40.7K ﹤0.01% 1616
2024
Q3
$1.14M Hold
55,696
0.01% 1318
2024
Q2
$1.25M Buy
55,696
+9,200
+20% +$206K 0.01% 1234
2024
Q1
$1.28M Hold
46,496
0.01% 1160
2023
Q4
$1.42M Hold
46,496
0.01% 1124
2023
Q3
$1.47M Hold
46,496
0.01% 1039
2023
Q2
$1.9M Buy
46,496
+2,465
+6% +$101K 0.01% 951
2023
Q1
$1.64M Hold
44,031
0.01% 983
2022
Q4
$1.54M Buy
44,031
+3,930
+10% +$137K 0.01% 1008
2022
Q3
$2.24M Buy
40,101
+917
+2% +$51.3K 0.02% 829
2022
Q2
$2.03M Buy
39,184
+1,822
+5% +$94.3K 0.02% 900
2022
Q1
$2.72M Buy
37,362
+13,209
+55% +$960K 0.02% 861
2021
Q4
$2.86M Hold
24,153
0.02% 696
2021
Q3
$3.24M Buy
24,153
+1,369
+6% +$184K 0.03% 595
2021
Q2
$3.69M Buy
22,784
+2,841
+14% +$460K 0.03% 554
2021
Q1
$1.6M Hold
19,943
0.01% 948
2020
Q4
$1.08M Hold
19,943
0.01% 1094
2020
Q3
$396K Hold
19,943
﹤0.01% 1493
2020
Q2
$419K Buy
19,943
+4,202
+27% +$88.3K ﹤0.01% 1481
2020
Q1
$193K Hold
15,741
﹤0.01% 1718
2019
Q4
$231K Hold
15,741
﹤0.01% 1903
2019
Q3
$210K Hold
15,741
﹤0.01% 1917
2019
Q2
$258K Hold
15,741
﹤0.01% 1883
2019
Q1
$269K Hold
15,741
﹤0.01% 1816
2018
Q4
$215K Hold
15,741
﹤0.01% 1870
2018
Q3
$451K Hold
15,741
﹤0.01% 1601
2018
Q2
$431K Buy
15,741
+8,144
+107% +$223K 0.01% 1494
2018
Q1
$160K Hold
7,597
﹤0.01% 2005
2017
Q4
$146K Buy
+7,597
New +$146K ﹤0.01% 2081